LexDanaLexDanabeta
Inventor

Erik WeiKing Pong

Inventor
Temple City, CA, US

Overview

4→
Patents
2013–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations44%
C07KPeptides44%
A61KPreparations for medical, dental or toiletry purposes11%
PatentTitleYear
10,626,182Optimized antibodies that target CD1920209,803,020'Optimized antibodies that target CD19'20178,551,485'Anti-CD40 antibodies and methods of inhibiting proliferation of CD40 expressing cells'20138,524,867'Optimized antibodies that target CD19'2013

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2013–2020Patents assigned to XENCOR INC (4)· patent assignee history
2013Patents assigned to BERNETT MATTHEW J (2)· patent assignee history
2013Patents assigned to CHU SEUNG YUP (2)· patent assignee history
2013Patents assigned to DESJARLAIS JOHN R (2)· patent assignee history
2013Patents assigned to KARKI SHER BAHADUR (2)· patent assignee history
2013–2020Based in Temple City, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
XENCOR INC42013–2020
BERNETT MATTHEW J22013
CHU SEUNG YUP22013
DESJARLAIS JOHN R22013
KARKI SHER BAHADUR22013
Locations
LocationPatentsSpan
Temple City, California, US42013–2020